Approved Projects
Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.
| Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
|---|---|---|---|---|---|
| Use of analgesic medications and risks of breast and endometrial cancer among women in the PLCO cohort | Kayleigh Majercak | University of Arkansas for Medical Sciences | PLCO | Jun 20, 2013 | PLCO-37 |
| Use of Artificial Intelligence to develop an automated, outcome-baaed, prostate cancer grading system. | Michael Donovan | University of Miami | PLCO | Jul 2, 2021 | PLCOI-803 |
| Use of biometric data in cancer prediction | Bonny Banerjee | University of Memphis | PLCO | Jan 28, 2021 | PLCOI-722 |
| Use of biometric data in pancreatic cancer prediction | Bonny Banerjee | University of Memphis | PLCO | Apr 10, 2019 | PLCO-469 |
| Use of deep learning to predict response of treatment for late stage lung cancer patients. | Monika Mehta | SGInnovate - Entrepreneur First | PLCO | Oct 3, 2019 | PLCOI-531 |
| Use of Digital Pathology and Artificial Intelligence for Prostate Cancer Risk Stratification | Eric Li | Northwestern University Feinberg School of Medicine | PLCO | Dec 10, 2021 | PLCOI-876 |
| Use of genetic ancestry versus self-reported race/ethnicity to predict lung-cancer risk in the PLCO | Hormuzd Katki | NCI | PLCO | Dec 8, 2021 | PLCO-875 |
| Use of GWAS data to address the association between Human Leukocyte Antigen (HLA) and cancer | Zhiwei Liu | National Cancer Institute | PLCO | Jun 22, 2018 | PLCO-375 |
| Use of head and neck cancer dataset | Monika Khurana | Independent | PLCO | Sep 20, 2017 | PLCO-306 |
| Use of Machine Learning and Decision Classifiers in the Analysis of PLCO Ovarian Data | Katherine Andriole | Brigham and Women's Hospital, Harvard Medical School | PLCO | Mar 29, 2016 | PLCO-201 |
| Use of neural networks in tissue abnormality detection | Rafal Grzeszczuk | AGH University of Science and Technology | NLST | Apr 11, 2017 | NLST-299 |
| Use of PLCO data to evaluate the performance of cancer risk models | Thomas Ahearn | Division of Cancer Genetics and Epidemiology, NCI | PLCO | Aug 22, 2022 | PLCO-1025 |
| USE OF PLCO IMAGING DATASET FOR MACHINE LEARNING PROJECTS | Mannudeep Kalra | Massachusetts General Hospital | PLCO | May 29, 2018 | PLCO-366 |
| Use of prescriptive analytics in the desing of dynamic treatment regimes for breast cancer. | Gustavo Mendoza Olguin | Autonomous University of Puebla | HIPB | Jun 14, 2022 | HIPB-9 |
| Use of previous-day recalls of physical activity and sedentary behavior in epidemiologic studies: results from four instruments | Charles Matthews | NCI / DCEG / Metabolic Epidemiology Branch | IDATA | Aug 21, 2018 | IDATA-25 |
| Use of Radiomics and AI To Predict Malignancy in Indeterminate Lung Nodules | Richard Lee | The Royal Marsden Hospital | NLST | Nov 19, 2019 | NLST-593 |
| Use of Regression Discontinuity to Measure the Effect of PSA Screening | Jonathan Shoag | None | PLCO | May 28, 2014 | PLCO-90 |
| Use of the NLST CT and CXR Data to Better Understand Laten Tuberculosis and Risk of DIsease Progression | William Stringer | Harbor-UCLA Medical Center - LABIOMED | NLST | Feb 17, 2016 | NLST-194 |
| Use of Tobacco Biomarkers in Lung Cancer Risk Assessment | Christine Lambert | University of Minnesota | PLCO | Jan 30, 2020 | PLCO-563 |
| Using AI to predict cardiovascular disease | yuankai wang | University of Liverpool | NLST | Aug 8, 2023 | NLST-1110 |